Chiral pyrimidinyl-piperazine carboxamide derivatives as potent yeast α-glucosidase inhibitors
Abstract α-Glucosidase is an important target in treating type 2 diabetes, and thus, the inhibition of this enzyme could delay sugar digestion and avoid postprandial hyperglycemia. Previous studies revealed that some pyrimidine and piperazine derivatives showed good affinity towards α-glucosidase. I...
Saved in:
| Main Authors: | Noval Herfindo, Pirun Mikled, Neni Frimayanti, Thanyada Rungrotmongkol, Warinthorn Chavasiri |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Nature Portfolio
2025-07-01
|
| Series: | Scientific Reports |
| Online Access: | https://doi.org/10.1038/s41598-025-06104-8 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Substituted piperazine conjugated to quinoline-thiosemicarbazide as potent α-glucosidase inhibitors to target hyperglycemia
by: Mehran Ghasemi, et al.
Published: (2025-01-01) -
Synthesis and Molecular Docking Study of 4-(3-(2-Chlorophenyl)-5-(2-Methoxyphenyl)-4,5-Dihydro-1H-Pyrazol-1-yl) Benzenesulfonamide as Antibreast Cancer Agent
by: Eka Marisa Putri, et al.
Published: (2021-12-01) -
Discovery of thymol-fused chalcones as new competitive \(\alpha\)-glucosidase inhibitors: Design, synthesis, biological evaluation, and molecular modeling studies
by: Ade Danova, et al.
Published: (2024-12-01) -
Synthesis of piperazine-based benzimidazole derivatives as potent urease inhibitors and molecular docking studies
by: Delaram Shahriarynejad, et al.
Published: (2025-08-01) -
1-Phenyl-β-carboline-3-carboxamide-1,2,3-triazole-N-phenylacetamide hybrids as new α-glucosidase inhibitors
by: Elham Safaie, et al.
Published: (2025-05-01)